Economic evaluation of clodronate and zoledronate in patients diagnosed with metastatic bone disease from the perspective of public and third party payors in Brazil

Clinical Therapeutics (2011) - Comment
pubmed: 22019346 doi: 10.1016/j.clinthera.2011.09.025 issn: 1879-114x issn: 0149-2918

Marcelo Cunio Machado Fonseca, Gabriela Tannus Branco De Araújo, Helder Etto, Alexandre Schiola, Natália Santoni, Marcio Machado